Table 1.
Category | Number (%) | Lp(a) mg/dL Median (IQR) (n=29 765) |
Lp(a) nmol/L Median (IQR) (n=18 370) |
LDL-C mg/dL Median (IQR) (n=47 988) |
All patients (both genders) | 48 129* | 18.0 (7.9–57.1) | 42.0 (15.0–155.4) | 77.0 (58.4– 101.0) |
Male, n (%) | 35 670 (74.1) | 17.0 (7.1–52.2) | 37.8 (13.7–143.2) | 75.0 (58.0– 98.0) |
Female, n (%) | 12 459 (25.9) | 22.8 (9.0–73.0) | 54 (18.2–185.7) | 82.0 (62.0– 111.0) |
P values for gender comparison | <0.001 | <0.001 | <0.001 | |
Age category (years) | 48 135 | |||
<65, n (%) | 25 579 (53.1) | 19.0 (7.9–61.1) | 44.0 (15.0–161.0) | 78.0 (59.1– 104.0) |
≥65, n (%) | 22 556 (46.9) | 17.0 (7.9–53.0) | 40.0 (15.0–150.3) | 75.0 (58.0– 98.6) |
P value for ages ≥65 <65 | <0.001 | 0.04 | <0.001 | |
<75, n (%) | 42 472 (88.2) | 18.0 (7.8–58.6) | 42.0 (14.9–157.0) | 77.0 (58.8– 101.7) |
≥75, n (%) | 5663 (11.8) | 17.0 (8.0–49.5) | 40.7 (16.0–144.5) | 75.0 (58.0– 97.0) |
P value for ages ≥75 or <75 | 0.01 | 0.92 | <0.001 | |
Race or ethnicity | 48 135 | |||
White, n (%) | 32 339 (67.2) | 19.0 (8.0– 71.0) | 37.0 (14.0–152.0) | 77.0 (58.0– 102.5) |
Black/African-American, n (%) | 2023 (4.2) | 60.0 (22.2–93.0) | 125.8 (53.9–229.6) | 81.2 (60.4– 110.0) |
Asian, n (%) | 11 286 (23.5) | 17.1 (7.3–39.8) | 37.2 (15.0–102.0) | 74.6 (58.0– 94.7) |
Other, n (%) | 2458 (5.1) | 13.0 (5.6–44.2) | 25.9 (10.0–89.0) | 83.0 (63.0– 114.0) |
Hispanic/Latino, n (%) | 6014 (12.8) | 20.0 (8.0–68.1) | 34.5 (11.7–118.0) | 80.0 (61.0– 109.0) |
P value for black patients compared with other races or ethnicities | <0.001 | <0.001 | <0.001 |
*Six patients with missing/unknown gender.